A Study on Suicidality, Psychosis or Substance Abuse With Methylphenidate, Atomoxetine, Amphetamine/Dextroamphetamine or Lisdexamfetamine
Condition: Attention Deficit Disorder With Hyperactivity Interventions: Drug: Methylphenidate; Drug: Lisdexamfetamine; Drug: Atomoxetine; Drug: Amphetamine; Drug: Dextroamphetamine Sponsor: Janssen Research & Development, LLC Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 21, 2019 Category: Research Source Type: clinical trials